by Purdue University R. Claudio Aguilar, a Purdue University researcher, has developed a patented therapeutic strategy for Lowe syndrome by repurposing two drugs previously approved by the U.S. Food and Drug Administration. Credit: Purdue University College of Science photo/Alisha ReferdaPurdue University researchers have developed a patented therapeutic strategy for Lowe syndrome, an incurable and rare genetic...
